Eton Pharmaceuticals (ETON) Accumulated Depreciation & Amortization (2019 - 2024)
Historic Accumulated Depreciation & Amortization for Eton Pharmaceuticals (ETON) over the last 6 years, with Q4 2024 value amounting to $446000.0.
- Eton Pharmaceuticals' Accumulated Depreciation & Amortization rose 1291.14% to $446000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $446000.0, marking a year-over-year increase of 1291.14%. This contributed to the annual value of $446000.0 for FY2024, which is 1291.14% up from last year.
- Per Eton Pharmaceuticals' latest filing, its Accumulated Depreciation & Amortization stood at $446000.0 for Q4 2024, which was up 1291.14% from $434000.0 recorded in Q3 2024.
- Eton Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $605000.0 for Q3 2020, and its period low was $14000.0 during Q3 2022.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $370000.0 (2023), whereas its average is $276950.0.
- In the last 5 years, Eton Pharmaceuticals' Accumulated Depreciation & Amortization crashed by 9603.31% in 2021 and then soared by 263571.43% in 2023.
- Over the past 5 years, Eton Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $347000.0 in 2020, then plummeted by 55.33% to $155000.0 in 2021, then plummeted by 57.42% to $66000.0 in 2022, then soared by 498.48% to $395000.0 in 2023, then grew by 12.91% to $446000.0 in 2024.
- Its Accumulated Depreciation & Amortization was $446000.0 in Q4 2024, compared to $434000.0 in Q3 2024 and $422000.0 in Q2 2024.